InvestSMART

Integral Diagnostics Limited (ASX: IDX) - Announcements

Current share price for IDX : $2.140 0.02 (0.94%)+

ASX company news and announcements for Integral Diagnostics Limited (IDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Integral Diagnostics Limited (IDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Integral Diagnostics Limited (IDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Integral Diagnostics Limited (IDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$800 Results for the six months ended 31 December 2016 23 Feb 2017 8:25AM $1.090 $2.140 risen by 96.33%
$800 Dividend/Distribution - IDX 23 Feb 2017 8:23AM $1.090 $2.140 risen by 96.33%
$800 Appendix 4D and Interim Financial Report 31 December 2016 23 Feb 2017 8:22AM $1.090 $2.140 risen by 96.33%
$800 Integral Diagnostics Limited 2017 Interim Result 1 Feb 2017 11:06AM $1.150 $2.140 risen by 86.09%
$800 Becoming a substantial holder from IFL 29 Nov 2016 4:47PM $1.170 $2.140 risen by 82.91%
$800 Response to speculation on a possible merger acquisition 23 Nov 2016 10:51AM $1.190 $2.140 risen by 79.83%
$800 Results of Meeting 18 Nov 2016 1:06PM $1.290 $2.140 risen by 65.89%
$800 CEO Presentation 18 Nov 2016 9:12AM $1.480 $2.140 risen by 44.59%
$800 Chairman's Address to Shareholders 18 Nov 2016 9:07AM $1.480 $2.140 risen by 44.59%
$800 Managing Director & CEO Succession 18 Nov 2016 9:01AM $1.480 $2.140 risen by 44.59%
$800 IDX secures 5 year contract with WACHS 16 Nov 2016 9:40AM $1.510 $2.140 risen by 41.72%
$800 Notice of Annual General Meeting/Proxy Form 18 Oct 2016 11:13AM $1.600 $2.140 risen by 33.75%
$800 Change of Director's Interest Notice - Chien Ho 28 Sep 2016 12:05AM $1.530 $2.140 risen by 39.87%
$800 Appendix 4G and Corporate Governance Statement 26 Sep 2016 8:28AM $1.570 $2.140 risen by 36.31%
$800 Annual Report to shareholders 26 Sep 2016 8:28AM $1.570 $2.140 risen by 36.31%
$800 Change of Director's Interest Notice - Sally Sojan 9 Sep 2016 3:30PM $1.580 $2.140 risen by 35.44%
$800 IDX global pilot with Siemens Healthineers 6 Sep 2016 12:24AM $1.590 $2.140 risen by 34.59%
$800 Ceasing to be a substantial holder 1 Sep 2016 4:59PM $1.650 $2.140 risen by 29.70%
$800 Becoming a substantial holder 31 Aug 2016 5:10PM $1.630 $2.140 risen by 31.29%
$800 Becoming a substantial holder 30 Aug 2016 5:40PM $1.690 $2.140 risen by 26.63%
$800 Change in substantial holding 30 Aug 2016 5:09PM $1.690 $2.140 risen by 26.63%
$800 Ceasing to be a substantial holder 30 Aug 2016 4:54PM $1.690 $2.140 risen by 26.63%
$800 Becoming a substantial holder 29 Aug 2016 4:51PM $1.690 $2.140 risen by 26.63%
$800 Change in substantial holding 29 Aug 2016 3:09PM $1.675 $2.140 risen by 27.76%
$800 CEO & CFO Presentation of FY16 Results 25 Aug 2016 8:47AM $1.760 $2.140 risen by 21.59%

701 - 725 of 788 results

Page 29 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.